Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Entellus Medical Inc
Leading provider of devices for minimally invasive sinus surgery
Transaction Summary
Revenue has increased rapidly to $59M run rate and 26% YoY growth
Completed IPO in January 2015 raising $78M
Well-positioned as an acquisition target; significant premiums paid as revenues approach ~$100M
Plymouth, MN
NASDAQ: ENTL
Contact:
Guido J. Neels
www.entellusmedical.com
IPO
Acquisition
Acquired by: Stryker
Exit date: February 28, 2018
Related News
Entellus Medical, Inc. Announces Pricing of Initial Public Offering
Centers for Medicare/Medicaid Services Establishes Coding and Payment for Eustachian Tube Balloon
Entellus Medical Inc. Completes Series E Financing Totaling $35 Million
Entellus Medical Announces Presentation of Positive Clinical Results in Pediatric Patients